Eris Life Standalone June 2024 Net Sales at Rs 456.69 crore, up 11.04% Y-o-Y
August 05, 2024 / 13:50 IST
Reported Standalone quarterly numbers for Eris Lifesciences are:Net Sales at Rs 456.69 crore in June 2024 up 11.04% from Rs. 411.29 crore in June 2023.
Quarterly Net Profit at Rs. 17.04 crore in June 2024 down 84.61% from Rs. 110.74 crore in June 2023.
EBITDA stands at Rs. 128.54 crore in June 2024 down 19.42% from Rs. 159.52 crore in June 2023.
Eris Life EPS has decreased to Rs. 1.25 in June 2024 from Rs. 8.14 in June 2023.
| Eris Life shares closed at 1,121.00 on August 02, 2024 (NSE) and has given 25.67% returns over the last 6 months and 40.21% over the last 12 months. |
| Eris Lifesciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 449.17 | 332.25 | 411.29 | | Other Operating Income | 7.52 | 9.05 | -- | | Total Income From Operations | 456.69 | 341.30 | 411.29 | | EXPENDITURE | | Consumption of Raw Materials | 24.40 | 17.74 | 26.17 | | Purchase of Traded Goods | 120.41 | 37.17 | 72.18 | | Increase/Decrease in Stocks | -14.29 | 10.40 | -25.25 | | Power & Fuel | -- | -- | -- | | Employees Cost | 103.75 | 79.52 | 90.36 | | Depreciation | 45.55 | 29.14 | 20.16 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 99.04 | 117.08 | 92.32 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 77.83 | 50.25 | 135.34 | | Other Income | 5.16 | 20.39 | 4.03 | | P/L Before Int., Excpt. Items & Tax | 82.99 | 70.64 | 139.36 | | Interest | 56.17 | 28.89 | 6.84 | | P/L Before Exceptional Items & Tax | 26.82 | 41.75 | 132.52 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 26.82 | 41.75 | 132.52 | | Tax | 9.78 | 2.24 | 21.78 | | P/L After Tax from Ordinary Activities | 17.04 | 39.51 | 110.74 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 17.04 | 39.51 | 110.74 | | Equity Share Capital | 13.61 | 13.60 | 13.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.25 | 2.90 | 8.14 | | Diluted EPS | 1.25 | 2.90 | 8.13 | | EPS After Extra Ordinary | | Basic EPS | 1.25 | 2.90 | 8.14 | | Diluted EPS | 1.25 | 2.90 | 8.13 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
